INTBREW
Investo's verdict, shared with you
No fair value published
The derivation ran and was refused by our own plausibility checks — so we publish no number rather than a plausible-looking one.
Why
Our valuation methods disagree
The earnings-based and book-based readings of this company differ by more than 2.5×. That spread is real information, but averaging it would manufacture a number no method actually produced.
What we would need
- Earnings and book value drawn from the same set of accounts, so the two legs can be reconciled.
Show what the engine computed
Method spread · 2.59× between the highest and lowest valuation leg.
Methods disagree · The valuation legs disagree by 2.59x (Blended P/E band ₦5.93 vs Blended P/B band ₦15.38). No point estimate is defensible until the inputs are reconciled.
INTBREW trades at ₦10.65, representing a 21% premium to the blended base fair value of ₦8.77 and a 79% premium to the P/E-anchored fair value of ₦5.93, against a Q2-2026 EPS run-rate of ₦0.38 that implies a trailing P/E of ~28x versus a sector median of 15.76x. The stock is earnings-expensive by any defensible metric, though a P/B lens (fair value ₦15.38 vs current ₦10.65) suggests the balance sheet carries unrecognised value, creating an irreconcilable internal conflict that suppresses conviction materially. With ROE of 12.4%, modest but positive profitability momentum, and no dividend signal, the risk/reward at current levels does not favour new capital deployment.
Verdict published 2026-08-18 · fundamentals through FY2026 · reviewed as the data changes
Verdict moderated to Watch — Avoid was refused
Committee scores Value POSITIVE (overall constructive); an "avoid" against our own committee is not publishable without a re-derivation.
Source: NGX live market data · Investo intelligence. Educational only — not financial advice.